Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
2008-005709-20Phase 2Completed
Phase 2, open-label, single-arm trial of simeprevir in hepatitis C virus infection, sponsored by Tibotec. Primary endpoint: Antiviral activity of TMC435350 over 7 days. Started Nov 2008; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on 2008-005709-20.